Project Details
Description
Randomized Double-Blind Phase II Trial of Everolimus versus Placebo as Adjuvant Therapy in Patients with Locally Advanced Squamous Cell Cancer of the Head and Neck (SCCHN)
| Status | Finished |
|---|---|
| Effective start/end date | 2/1/11 → 12/1/15 |
Funding
- UNIVERSITY OF CHICAGO
- NOVARTIS PHARMACEUTICALS CORPORATION
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.